TREA

79176495 - PATHOMICS

Follow

Information

  • Trademark
  • 79176495
  • Serial Number
    79176495
  • Registration Number
    4962140
  • Filing Date
    January 22, 2015
    9 years ago
  • Registration Date
    May 24, 2016
    8 years ago
  • Transaction Date
    September 16, 2023
    a year ago
  • Status Date
    November 07, 2022
    2 years ago
  • Published for Opposition Date
    March 08, 2016
    8 years ago
  • Location Date
    November 07, 2022
    2 years ago
Information
Mark Drawing Code
4000
Mark Identification
PATHOMICS
Case File Statements
  • GS0051: [ Pharmaceutical and medical compositions for human and/or veterinary use, namely, for the treatment of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, metabolic disorders, anti-infectives, occular disorders, and for use in oncology; vaccines for human beings and/or animals; adjuvants for use with vaccines; biological laboratory preparations for medical and/or veterinary purposes, namely, for the treatment of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, metabolic disorders, anti-infectives, occular disorders, and for use in oncology; chemical preparations and reagents for medical, pharmaceutical and veterinary purposes, namely, for the treatment of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, metabolic disorders, anti-infectives, occular disorders, and for use in oncology; viruses for the treatment of humans and/or animals; diagnostic preparations for medical purposes; in-vitro diagnostic preparations for medical purposes; in-vivo diagnostic preparations for medical purposes ]
  • GS0351: Investigation and research services relating to cost and business efficiency, all relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; systemization and compilation of medical information into computer databases; business statistical information all relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; registration services for diagnostic testing; product demonstration services in the field of diagnostic testing; computer database management services, namely, database management services that allow for information storage in the fields of diagnostic testing and results, database management of medical, hospital, insurance and billing records and information storage and retrieval services in the fields of diagnostic testing and preparations for the treatment, monitoring or diagnosis of disease; trade information services in the fields of medical, health, or clinical care; database management of diagnostic testing and results, database management of medical, hospital, insurance or billing records; collation and provision of business information for the purpose of providing referral services in the fields of medical, health or clinical care; collation and provision of business information in the fields of medicine and pharmacy; collation and provision of business information regarding medical and pharmaceutical testing procedures; collation and provision of business information regarding disease conditions and disease prevention; collation and provision of business information regarding medical, hospital, insurance or billing records
  • GS0421: Medical research services; conducting clinical trials for others; medical research laboratory services; medical research laboratory services for the analysis of samples taken from patients; scientific analysis and research services; product development relating to pharmaceuticals, medicines, medicaments and veterinary products; medical and health care research services, namely, clinical testing services, physician testing services for assisting pharmacists, pharmacy testing services, medical laboratory and testing services; medical research into the causes and treatment of influenza and the common cold
Case File Event Statements
  • 9/16/2023 - a year ago
    39 - PARTIAL INVALIDATION PROCESSED BY THE IB Type: INNP
  • 8/8/2023 - a year ago
    38 - PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INPS
  • 8/8/2023 - a year ago
    37 - INVALIDATION PROCESSED Type: INPC
  • 7/7/2023 - a year ago
    36 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 11/7/2022 - 2 years ago
    35 - NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Type: NA71
  • 11/7/2022 - 2 years ago
    34 - REGISTERED - PARTIAL SEC 71 ACCEPTED Type: 71.P
  • 10/31/2022 - 2 years ago
    33 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP
  • 5/24/2022 - 2 years ago
    32 - POST REGISTRATION ACTION MAILED - SEC.71 Type: PR71
  • 5/23/2022 - 2 years ago
    31 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 11/11/2021 - 3 years ago
    30 - TEAS SECTION 71 RECEIVED Type: ES71
  • 5/24/2021 - 3 years ago
    29 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 5/9/2019 - 5 years ago
    28 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 11/24/2016 - 8 years ago
    27 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 9/16/2016 - 8 years ago
    26 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 8/25/2016 - 8 years ago
    25 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 8/25/2016 - 8 years ago
    24 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 8/24/2016 - 8 years ago
    23 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 5/24/2016 - 8 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/8/2016 - 8 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/8/2016 - 8 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/4/2016 - 8 years ago
    19 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 2/17/2016 - 8 years ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/17/2016 - 8 years ago
    17 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 2/17/2016 - 8 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/1/2016 - 8 years ago
    15 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 1/26/2016 - 8 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/25/2016 - 8 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/25/2016 - 8 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/25/2016 - 8 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 1/12/2016 - 9 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/31/2015 - 9 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 12/4/2015 - 9 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 12/4/2015 - 9 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/2/2015 - 9 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/1/2015 - 9 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/25/2015 - 9 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 11/21/2015 - 9 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/21/2015 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/19/2015 - 9 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR